These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30160988)

  • 21. Preoperative 3-T diffusion-weighted MRI for the qualitative and quantitative assessment of extracapsular extension in patients with intermediate- or high-risk prostate cancer.
    Lawrence EM; Gallagher FA; Barrett T; Warren AY; Priest AN; Goldman DA; Sala E; Gnanapragasam VJ
    AJR Am J Roentgenol; 2014 Sep; 203(3):W280-6. PubMed ID: 25148185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.
    Salami SS; Ben-Levi E; Yaskiv O; Turkbey B; Villani R; Rastinehad AR
    J Magn Reson Imaging; 2017 Feb; 45(2):610-616. PubMed ID: 27405584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging.
    Giannotti E; Waugh S; Priba L; Davis Z; Crowe E; Vinnicombe S
    Eur J Radiol; 2015 Sep; 84(9):1729-36. PubMed ID: 26078100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.
    Rosenkrantz AB; Triolo MJ; Melamed J; Rusinek H; Taneja SS; Deng FM
    J Magn Reson Imaging; 2015 Mar; 41(3):708-14. PubMed ID: 24616064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apparent diffusion coefficient measurements in diffusion-weighted magnetic resonance imaging of the anterior mediastinum: inter-observer reproducibility of five different methods of region-of-interest positioning.
    Priola AM; Priola SM; Parlatano D; Gned D; Giraudo MT; Giardino R; Ferrero B; Ardissone F; Veltri A
    Eur Radiol; 2017 Apr; 27(4):1386-1394. PubMed ID: 27516357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.
    Lim HK; Kim JK; Kim KA; Cho KS
    Radiology; 2009 Jan; 250(1):145-51. PubMed ID: 19017927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI of the Prostate With and Without Endorectal Coil at 3 T: Correlation With Whole-Mount Histopathologic Gleason Score.
    Dhatt R; Choy S; Co SJ; Ischia J; Kozlowski P; Harris AC; Jones EC; Black PC; Goldenberg SL; Chang SD
    AJR Am J Roentgenol; 2020 Jul; 215(1):133-141. PubMed ID: 32160050
    [No Abstract]   [Full Text] [Related]  

  • 28. Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology.
    Glazer DI; Hassanzadeh E; Fedorov A; Olubiyi OI; Goldberger SS; Penzkofer T; Flood TA; Masry P; Mulkern RV; Hirsch MS; Tempany CM; Fennessy FM
    Abdom Radiol (NY); 2017 Mar; 42(3):918-925. PubMed ID: 27770164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG-ACRIN Research Group (ACRIN 6701).
    Boss MA; Snyder BS; Kim E; Flamini D; Englander S; Sundaram KM; Gumpeni N; Palmer SL; Choi H; Froemming AT; Persigehl T; Davenport MS; Malyarenko D; Chenevert TL; Rosen MA
    J Magn Reson Imaging; 2022 Sep; 56(3):668-679. PubMed ID: 35143059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. All over the map: An interobserver agreement study of tumor location based on the PI-RADSv2 sector map.
    Greer MD; Shih JH; Barrett T; Bednarova S; Kabakus I; Law YM; Shebel H; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    J Magn Reson Imaging; 2018 Aug; 48(2):482-490. PubMed ID: 29341356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer.
    Krishna S; Lim CS; McInnes MDF; Flood TA; Shabana WM; Lim RS; Schieda N
    J Magn Reson Imaging; 2018 Jan; 47(1):176-185. PubMed ID: 28387981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Length of capsular contact for diagnosing extraprostatic extension on prostate MRI: Assessment at an optimal threshold.
    Rosenkrantz AB; Shanbhogue AK; Wang A; Kong MX; Babb JS; Taneja SS
    J Magn Reson Imaging; 2016 Apr; 43(4):990-7. PubMed ID: 26395278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of measurement method on interobserver variability of apparent diffusion coefficient of lesions in prostate MRI.
    Takahashi H; Yoshida K; Kawashima A; Lee NJ; Froemming AT; Adamo DA; Khandelwal A; Bolan CW; Heller MT; Hartman RP; Kim B; Philbrick KA; Carter RE; Mynderse LA; Humphreys MR; Cai JC; Takahashi N
    PLoS One; 2022; 17(5):e0268829. PubMed ID: 35604891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inter-observer variation and diagnostic efficacy of apparent diffusion coefficient (ADC) measurements obtained by diffusion-weighted imaging (DWI) in small renal masses.
    Ponhold L; Javor D; Heinz-Peer G; Sevcenco S; Hofstetter M; Baltzer PA
    Acta Radiol; 2016 Aug; 57(8):1014-20. PubMed ID: 26486599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADC Metrics From Multiparametric MRI: Histologic Downgrading of Gleason Score 9 or 10 Prostate Cancers Diagnosed at Nontargeted Transrectal Ultrasound-Guided Biopsy.
    Sadoughi N; Krishna S; McInnes MDF; Flood TA; Breau RH; Morash C; Schieda N
    AJR Am J Roentgenol; 2018 Sep; 211(3):W158-W165. PubMed ID: 29995495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extraprostatic Tumor Extension: Comparison of Preoperative Multiparametric MRI Criteria and Histopathologic Correlation after Radical Prostatectomy.
    Park KJ; Kim MH; Kim JK
    Radiology; 2020 Jul; 296(1):87-95. PubMed ID: 32368959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
    Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
    Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study.
    Almansour H; Schick F; Nachbar M; Afat S; Fritz V; Thorwarth D; Zips D; Bertram F; Müller AC; Nikolaou K; Othman AE; Wegener D
    Radiol Oncol; 2023 Jun; 57(2):184-190. PubMed ID: 37341194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
    Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
    J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.
    Rosenkrantz AB; Hindman N; Lim RP; Das K; Babb JS; Mussi TC; Taneja SS
    J Magn Reson Imaging; 2013 Sep; 38(3):694-700. PubMed ID: 23371846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.